Stay updated on Amivantamab Clinical Trial in Advanced NSCLC

Sign up to get notified when there's something new on the Amivantamab Clinical Trial in Advanced NSCLC page.
Latest website image capture
Clouds background image

Latest updates to the Amivantamab Clinical Trial in Advanced NSCLC page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added a minor site revision tag (Revision: v3.4.2) and removed a general government funding notice; the study details and page content remain unchanged.
    Difference
    0.3%
    Check dated 2026-02-11T01:37:21.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A government funding lapse notice was added indicating possible delays in updates and that the NIH Clinical Center remains open, with links to update status at opm.gov. The page revision tag was updated from v3.4.0 to v3.4.1, and the previous revision tag v3.4.0 was removed.
    Difference
    0.3%
    Check dated 2026-02-03T23:44:04.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Glossary toggle was added and the 'No FEAR Act data' footer note was removed; no changes to core study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    76%
    Check dated 2026-01-27T23:42:42.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The additions and deletions primarily reflect updates to the study record timestamps (e.g., last update dates) and historical entries, with no changes to the core details such as eligibility criteria, interventions, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-20T21:43:13.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The page now lists Revision: v3.3.4, replacing the previous Revision: v3.3.3.
    Difference
    0.0%
    Check dated 2026-01-13T19:23:14.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The page adds a unified 'Locations' section listing sites (California, Florida, Illinois, Maryland, Massachusetts, Michigan, Minnesota, Missouri, New York, Oregon, Pennsylvania, Texas, Virginia, Ontario) and removes the prior state-specific location subsections; the 'HHS Vulnerability Disclosure' footer link is removed.
    Difference
    1%
    Check dated 2025-12-23T08:09:51.000Z thumbnail image

Stay in the know with updates to Amivantamab Clinical Trial in Advanced NSCLC

Enter your email address, and we'll notify you when there's something new on the Amivantamab Clinical Trial in Advanced NSCLC page.